Explosive Long Plays: 10/12 Top Performers

Today, we take a look at some of the most explosive long-plays suggested by the NewsQuantified platform this week. As markets churn near record highs, we continue identifying long plays that blow past market averages.

Today's report features two acquisitions and a clinical trial result: all three stocks jumped over 50%.

1.   Majestic Oil & Gas (MJOG): Doubles in value after announcing acquisition plan.

On Tuesday, Majestic Oil and Gas announced that they have signed a letter of intent to acquire the Florida Based ATC Holdings. ATC provides a number of industrial services, especially those associated with cleaning industrial ponds and storage tanks.

Investors loved the acquisition plan, buying MJOG to the tune “majestic” 100%+ gains. ATC was previously privately traded; the acquisition will substantially improve capital access for MJOG’s new subsidiary.

In addition to developing resource fields, Majestic Oil and Gas owns a variety of specialized industrial companies.

2.    Cleantech Solutions   (CLNT): shoots upward on prospective acquisition news.

On Monday, Cleantech solutions announced that they have signed an exclusivity agreement to pursue terms to acquire Inspirit Studios. The acquisition would be conducted through Sharing Economy Investment Limited, a Cleantech subsidiary. The move was focused on Inspirit’s peer-to-peer courier app, Anyway, which has had successful recent trials in Hong Kong.

Cleantech’s stock shot higher on the news, flirting with gains near 150% before consolidating up around 57%.

Cleantech has its roots in the industrial dying business but now owns a diversified portfolio.

  1. Anaptysbio (ANAB): Stock doubles on positive clinical trial results.

ANAB’s stock shot up after announcing promising Phase 2 clinical trial results for its new antibody therapy for dermatitis, a skin condition. It was up over 100% at the time of this writing. 

ANAB is a clinical-stage pharma company developing novel antibody approaches focused on underserved medical needs in inflammation.

Diverse Plays, Great Profits: All in a single news day.

Keep checking our blog for daily updates on lucrative new-based stock plays, analyst actions, and more!

We analyze news events ranging from clinical trials in the pharmaceutical industry to routine earnings releases to major geopolitical shakeups.

Or, if you’re ready to move beyond the blog and experience the power of hedge-fund caliber news analysis in package that’s accessible to small investors, click here to sign up for a free training today. You’ll see how easy to use our platform really is—and how many profitable trades it can unlock

A powerful news analytics platform like NewsQuantified not only makes it easy to track the news, but to quickly compare news events with key financial information. Today’s plays make the power of this news-based trading approach clear. No small investor could be expected to track all these companies, diverse across industry, market cap, and valuation.

Yet they were all at the top of a single easy to use dashboard in the NewsQuantified platform. We make it simple to find strong, diverse plays in any market environment.

Subscribe to Email Updates